pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·5h ago·1 min read
save

Former Stanford president posts emails to counter fraud claims in new book

Aug 27, 2026·read at STAT ↗Negative

Former Stanford president Marc Tessier-Lavigne has posted a more than 3,000-word response on his lab website, including emails with former colleagues, to dispute claims that he fabricated research results.

The claims were raised in Theo Baker’s book "How to Rule the World," which portrays Tessier-Lavigne as a case of scientific misconduct related to a 2009 neurodegeneration paper published while he was at Genentech.

In his rebuttal, Tessier-Lavigne argues the study was valid and uses the released correspondence to support his defense, seeking to restore his reputation after a misconduct investigation led to his resignation as Stanford’s president.

The episode has renewed attention on research integrity issues within academic-industry collaborations in the biotech sector.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Former Stanford president releases emails to rebut fraud and cover-up allegations in new book”

read at STAT ↗
471 words · retrieved 4h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
GENENTECH2
topics
Obesity

related stories

  • 3d agoRoche bets up to $2.3B in Hanmi pact for next-gen weight loss drugBioSpace
  • 3d agoRoche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanismFierce Biotech
  • Aug 20Roche pours $750M into Oregon manufacturing plant as obesity push expandsBioSpace
  • Aug 20Chutes & Ladders—Neumora shuffles leadership ahead of INDFierce Biotech
  • Jul 16Chutes & Ladders—Cue lines up new CMO and research headFierce Biotech